Navigation Links
Hard To Treat Diseases (HTDS) Begins Formulating SPC company for merger With Mellow Hope
Date:1/26/2009

SHENZHEN, China, Jan. 26 /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS) http://www.htdsmedical.com/ the company is pleased to announce that having received clearances from its Chief Project Scientist, Director, R&D, Andrea Zecevic as a viable project for HTDS to merge with Mellow Hope; the company commenced the formulation of an off shore (Belize) special purpose company (SPC). An SPC is required under the Chinese laws before a China mainland company can be merged into a USA based public company such as Hard To Treat Diseases (HTDS).

Cathy Zhao, Chief Admin. Officer for the company said this is a relatively minor task that we need to complete before the actual merger can take place. Our corporate advisors in Canada have done many Asia based SPC and advise us that this should be completed fairly shortly with our targeted early February merger date remaining undisturbed.

In other company news, the company has appointed 2 new officers to the company and the board. They are Li Qiang COO, and Tarun Gupta, Marketing director. Both individuals act in the same capacity with Mellow Hope.

Mellow Hope is China based and the biggest exporter of Biological Vaccines in China. It has a product line that encompasses vaccines for influenza, tetanus, diphtheria and other diseases; Blood based products including human rabies immunoglobulin; and active pharmaceutical ingredient (or APIs) for injection such as celestatin.

Mellow Hope revenues are currently in excess of $15 million USD, and growing.

The company will provide further details as they become available.

Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: Certain information contained in this release contains forward-looking statements that involve risk and uncertainties, including but not limited to, those relating to development and expansion activities, domestic and global conditions, and market competition.

CONTACT: For scientific dialogue and any medical inquiry only please contact Andrea Rubio Zecevic via e-mail at azconsulting2001@gmail.com. For any corporate matters the readers should contact the company directly at corporate@htdsmedical.com


'/>"/>
SOURCE Hard to Treat Diseases
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Renaissance Laser & Vein Institute (LaserandVeinclinic.com) Pearl Treatment
2. Menstrual Bleeding Treatment Safer Than Thought
3. Traditional Nonsurgical GERD Treatments Not Impressive
4. Hard To Treat Diseases (HTDS) Launches On Line Cosmetics Products
5. UCSF Finds Potential New Antibody Treatment for Autoimmune Diseases
6. North Carolina Dentists Team Up To Treat Needy Children
7. Survey could help pediatricians better treat patients
8. New treatment option for latent tuberculosis
9. New treatment reduces severity of asthma attacks in preschoolers
10. Gender May Influence Heart Failure Treatment
11. Georgia Ranks Fourth in the Number of Untreated HIV Patients in the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2017)... ... April 30, 2017 , ... TransLiquid Cartoon is a ... X. Editors can pick and choose from a variety of liquid transitions that ... shadows using simple color swabs. Utilize on-screen controls to fully manipulate transitions through ...
(Date:4/29/2017)... Aliso Viejo, CA (PRWEB) , ... April 29, 2017 , ... ... effects. Seamlessly transition from one video to the next without having to set ... bleeding, ripping, and blasting transitions to enhance your video production. , TransDark features dynamic ...
(Date:4/28/2017)... ... 2017 , ... An April 24th article on Yahoo! Beauty discusses the case of ... of a weight loss surgery. The woman, declaring “I will not hate my body anymore!” ... her dramatic weight loss. Dr. Feiz & Associates notes that, while it often refers its ...
(Date:4/28/2017)... ... April 28, 2017 , ... Beginning in 2017, Ridgecrest Herbals will ... begins with the popular ClearLungs Extra Strength formula. To ensure that the effectiveness of ... the following ways:, , Removal of the homeopathic element , ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... . These lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on ... or disconnect ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... Calif. , April 19, 2017  IRIDEX Corporation ... will release financial results for the first quarter 2017 ... 2017.  The Company,s management team will host a corresponding ... p.m. ET. Investors interested in listening to ... 707-0665 for domestic callers or (703) 326-3030 for international ...
(Date:4/19/2017)... 19, 2017 The Global Effective Microorganisms ... 2022 report has covered and analysed the potential of Global ... market size, shares and growth factors. The report identifies and ... opportunities in the global market. ... Browse 152 Tables and Figures, 6 Major Company Profiles, ...
(Date:4/19/2017)... April 19, 2017  Novartis today announced the ... Heart, Lung, and Blood Institute (NHLBI) of the ... of patients with treatment-naïve severe aplastic anemia (SAA) ... with eltrombopag at the initiation of and concurrently ... evaluated three sequential treatment groups, or cohorts. Cohort ...
Breaking Medicine Technology: